Form D · Pharmaceuticals
CoLucid Pharmaceuticals, Inc.
Durham, NC · CIK 0001348649
Offering snapshot reported Jan 26, 2015 · SEC filing
- Reported sold
- $37.1M Offering amount: $37.1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 12, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 26, 2015 | Initial | $37,100,000 | No comparison | 11 | SEC filing |
| Jul 11, 2013 | Amendment | $8,250,000 | $6,250,000vs Mar 3, 2011 | 7 | SEC filing |
| Jun 28, 2011 | Amendment | $3,500,000 | $1,500,000vs Mar 3, 2011 | 7 | SEC filing |
| Mar 3, 2011 | Initial | $2,000,000 | No comparison | 7 | SEC filing |
| Jan 26, 2010 | Amendment | $9,199,981 | No comparison | 8 | SEC filing |
| Jan 30, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 20, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 30, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 30, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 30, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-232838
Includes conversion of indebtedness.
New Series C Preferred Stock, and additional shares of Series A Preferred Stock and Series B Preferred Stock
Source: Form D, filed Jan 26, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel L Boeglin | Executive |
| Martin Edwards | Director |
| Timothy C. Gupton | Executive |
| Bernice Kuca | Executive |
| Luc Marengere | Director |
| Richard J. Markham | Director |
| Thomas P. Mathers | Director, Executive |
| Arthur M. Pappas | Director, Executive |
| Nadia Rupniak | Executive |
| Mathers P. Thomas | Director, Executive |
| Jesse I. Treu | Director |
| James F White | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2520 Meridian Parkway Suite 400
Durham, NC, 27713
Durham, NC, 27713